22 August 2022
Marechale Capital
plc
("Marechale" or the "Company")
Financial
Statements for the Year Ended 30 April
2022
Marechale Capital plc, an established City of London based corporate finance house
with a long-term track record and a strong reputation for advising
and financing high growth consumer brands, leisure, clean energy,
mineral extraction and technology companies, is pleased to announce
its audited final results for the year ended 30 April 2022 (the “Period”).
Financial Highlights
- Increased profit to £2,562,000 (FY21: £246,000)
- Significant increase in balance sheet to £3,630,000 (FY21:
£686,000)
- Revenue of £622,000 (FY21: £400,000)
- Investments and warrants in client companies generated gains of
£2,716,000 (FY21: £412,000)
- Successful fundraise of £207,000 in March 2022
- Strategic investment of £160,000 from Luke Johnson in October
2021
Operational Highlights
- Further equity funding for Fast2Fibre
- Additional funding secured for The Forest Road Brewing
Company
- Strategic funding advice given to Future Biogas, Chestnut Group
and the Burgh Island Hotel
- Luke Johnson took a 9% stake in
the Company in October 2021
- Hospitality clients are strongly positioned to expand and
capitalise on market opportunities
- Renewable energy and other corporate clients continue to
perform providing strong return opportunities for our
shareholders
Post Period Highlights
- Completion of fundraise for Weardale Lithium Ltd (“Weardale”);
Marechale’s total interest in Weardale is now 8.5%
Chairman’s Statement
Marechale is an established corporate finance house with a
long-term track record and a strong reputation in advising and
financing high growth consumer brands, leisure, clean energy, and
technology companies in the UK and Europe. Marechale also uses its balance sheet
to co-invest in its client companies, along with warrants and
founder equity, in order to create shareholder value. I am pleased
to provide the following update for the Period.
It has been an active year in the hospitality sector as a number
of businesses negotiated through the pandemic and Government
restrictions; two years of market uncertainty have now been
prolonged with the advent of war in Europe, which is compounding increasing
inflationary pressures, and discretionary spending is being
squeezed. However, against this challenging backdrop, we believe
that there are significant market opportunities for Marechale’s
clients.
The Company entered the Period with good levels of business
activity and funded clients in both the hospitality sector, as well
as clients in other high growth sectors. Completed projects include
further equity funding for the European telecommunications
technology company, Fast2Fibre, and additional funding for The
Forest Road Brewing Company, the award-winning London craft brewer.
Marechale continues to generate professional services income by
providing advice to its clients. In the last year, this included
strategic and funding advice for Future Biogas, Chestnut Group and
the Burgh Island Hotel. All these fundraisings were at premiums or
significant premiums to Marechale’s equity and warrant holdings. It
is pleasing to report that overall Marechale has had a record year
in increasing net asset value for shareholders.
One of the key strategic events of the last year was welcoming
Luke Johnson as a 9% shareholder as
reported in October 2021. Luke
provides a wealth of experience as one of the UK’s most successful
retail private equity (‘PE’) investors, and Marechale had been and
will continue to work closely with him.
In the clean energy space, general market uncertainty has also
impacted some of our corporate clients whose progress has been
delayed and resulted in some investor exits being postponed for the
next 12-18 months. We are, however, pleased to report that
significant progress has been made with the lithium extraction
business, Weardale Lithium Ltd, as announced on 09 August 2022, and that our pipeline of new and
increasingly diversified projects remains robust.
Weardale Lithium Ltd is Marechale’s largest investment, holding
500,000 founder shares and 22,400 Options with a combined value of
£2.8 million which has been recorded in the balance sheet. Weardale
has secured mineral extraction rights in Co. Durham via existing boreholes where there
is proven lithium in the brine hundreds of feet below the surface.
Since the initial fundraising in August
2021, the price of lithium has increased 300%, giving
Marechale cause to be optimistic for a positive future outcome.
During the last year Marechale has generated revenue of £622,000
(2021: £400,000), and, although our gross profit margin decreased
from 64% to 53%, owing to higher third-party commissions,
administrative expenses remained steady at £483,000 (2021:
£463,000).
Importantly, investments and warrants in client companies
generated unrealised gains of £2,716,000 (2021: £412,000). It is
worth noting that we have £1,393,000 of unused losses to offset
against any possible future tax liability on realisation.
I am delighted to announce an increased profit for the year of
£2,562,000 (2021: £246,000). During the same time, the balance
sheet value has increased significantly to £3,630,000 (2021:
£686,000), representing 3.8 pence per
share (2021: 0.8 pence per share),
due to adding both profit and new equity which is explained in full
in the Statement of Changes in Equity.
The Company’s focus is to use its reputation and deal flow as a
corporate finance adviser to build shareholder value in Marechale’s
balance sheet. This has been achieved by negotiating further equity
and warrant positions, and joint venture arrangements as part of
its terms of engagement with growth company clients. Marechale’s
historical investment performance has been excellent in this
regard, having achieved double digit internal rates of return
across all the companies that it has funded since 2010. We are
confident that our investments in Weardale Lithium, Burgh Island,
Chestnut Group, Fast2Fibre, Forest Road Brewery and Future Biogas,
amongst others, will deliver uplifts in value in due course.
The Company has continued with its strategy of utilising its
balance sheet to take enhanced positions in its client companies,
and embarked on two small capital raises, welcoming Luke Johnson’s
strategic investment of £160,000 in October
2021, and, secondly, raising a further £207,000 from
shareholders and new investors in March
2022.
Due to Marechale’s proven track record as a corporate finance
adviser in the £5-50 million Enterprise Value PE sector, the Board
remains optimistic that the Company will continue to generate
further uplifts on its current and future equity and warrant
investments, both in the short and longer term.
Mark Warde-Norbury
Chairman
22 August 2022
For further information please
contact:
Marechale Capital plc
Mark Warde-Norbury / Patrick Booth-Clibborn |
Tel: +44 (0)20 7628
5582 |
Cairn Financial Advisers LLP
(Nomad and Broker)
Jo Turner / Sandy Jamieson |
Tel: +44 (0)20 7213
0880 |
BlytheRay (Financial
PR)
Tim Blythe / Megan Ray / Madeleine Gordon-Foxwell |
Tel: +44
(0)20 7138 3204
marechalecapital@blytheray.com |
Statement of Comprehensive Income
For year ended 30 April 2022
|
|
|
|
|
Year
ended |
Year
ended |
|
|
|
|
|
30-Apr |
30-Apr |
|
|
|
|
|
2022 |
2021 |
|
|
|
|
|
(£) |
(£) |
|
|
|
|
|
|
|
Continuing operations |
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
|
|
621,573 |
399,929 |
Cost of sales |
|
|
|
|
(291,632) |
(144,507) |
|
|
|
|
|
|
|
Gross
profit |
|
|
|
|
329,941 |
255,422 |
|
|
|
|
|
|
|
Administrative expenses |
|
|
|
(483,499) |
(463,343) |
|
|
|
|
|
|
|
Operating
loss |
|
|
|
(153,558) |
(207,922) |
|
|
|
|
|
|
|
Other Income |
|
|
|
|
- |
44,354 |
Finance
expense |
|
|
|
(876) |
(1,063) |
Other
gains/(losses) |
|
|
|
2,716,237 |
410,516 |
|
|
|
|
|
|
|
Profit/
(loss) before tax |
|
|
|
2,561,803 |
245,886 |
|
|
|
|
|
|
|
Taxation |
|
|
|
|
- |
- |
|
|
|
|
|
|
|
Profit/
(loss) for the year on continuing operations |
|
2,561,803 |
245,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings/ (loss) per share |
|
|
(Pence) |
(Pence) |
|
|
|
|
|
|
|
Basic |
-
Continuing operations |
|
|
2.95 |
0.39 |
|
- Diluted |
|
|
|
2.70 |
0.35 |
|
|
|
|
|
|
|
Statement of Comprehensive Income |
|
|
|
|
|
|
|
|
|
|
Profit/
(loss) for the year |
|
|
|
2,561,803 |
245,886 |
|
|
|
|
|
|
|
Total
recognised comprehensive profit/ (loss) |
|
|
|
(all
attributable to owners of the company) |
|
2,561,803 |
245,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Financial Position
As at 30 April
2022
|
|
|
|
|
Year
ended |
Year
ended |
|
|
|
|
|
30-Apr |
30-Apr |
|
|
|
|
|
2022 |
2021 |
|
|
|
|
|
(£) |
(£) |
|
|
|
|
|
|
|
Current
assets |
|
|
|
|
|
Investment
in subsidiary and associate |
|
|
2 |
2 |
Equity
investments at fair value through profit and loss |
|
3,125,189 |
423,066 |
Warrants
at fair value through profit and loss |
|
146,589 |
90,013 |
Trade and
other receivables |
|
|
43,777 |
50,599 |
Cash and
cash equivalents |
|
|
413,970 |
233,287 |
|
|
|
|
|
|
|
Total
current assets |
|
|
|
3,729,527 |
796,967 |
|
|
|
|
|
|
|
Total
assets |
|
|
|
|
3,729,527 |
796,967 |
|
|
|
|
|
|
|
Current
liabilities |
|
|
|
|
|
Trade and
other payables |
|
|
|
(57,368) |
(61,213) |
Borrowings |
|
|
|
|
(10,000) |
(7,500) |
|
|
|
|
|
|
|
Total
current liabilities |
|
|
|
(67,368) |
(68,713) |
|
|
|
|
|
|
|
Net
current assets |
|
|
|
3,662,159 |
728,254 |
|
|
|
|
|
|
|
Long-term liabilities |
|
|
|
|
|
Borrowings |
|
|
|
|
(32,500) |
(42,500) |
|
|
|
|
|
|
|
Net assets |
|
|
|
|
3,629,659 |
685,754 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
Capital
and reserves attributable to equity shareholders |
|
|
|
|
|
|
|
|
|
Share capital |
|
|
|
|
763,023 |
643,690 |
Share
premium |
|
|
|
328,413 |
85,247 |
Reserve
for own shares |
|
|
|
(50,254) |
(50,254) |
Reserve
for share based payments |
|
|
62,312 |
42,709 |
Retained
profits/(losses) |
|
|
|
2,526,165 |
(35,638) |
|
|
|
|
|
|
|
|
|
|
|
|
3,629,659 |
685,754 |
|
|
|
|
|
|
|
Statement of Changes in Equity
For year ended 30 April 2022
|
|
Share
capital |
Share
premium |
Reserve for own shares |
Reserve for share based payments |
Retained earnings |
|
|
|
|
|
|
|
Company |
|
|
|
|
|
|
Balance at 30 April
2020 |
|
461,449 |
- |
(50,254) |
28,953 |
(281,524) |
|
|
|
|
|
|
|
Total comprehensive
income |
|
|
|
|
|
|
Charge/ profit for the
financial year |
|
- |
- |
- |
13,756 |
245,886 |
Issued in year* |
|
182,241 |
85,247 |
- |
|
|
Total comprehensive
income |
|
182,241 |
85,247 |
- |
13,756 |
245,886 |
|
|
|
|
|
|
|
Balance at 30 April
2021 |
|
643,690 |
85,247 |
(50,254) |
42,709 |
(35,638) |
|
|
|
|
|
|
|
Total comprehensive
income |
|
|
|
|
|
|
Charge/ profit for the
financial year |
|
- |
- |
- |
19,603 |
2,561,802 |
Issued in year* |
|
119,333 |
243,167 |
- |
|
|
Total comprehensive
income |
|
119,333 |
243,167 |
- |
19,603 |
2,561,802 |
|
|
|
|
|
|
|
Balance at 30 April
2022 |
|
763,023 |
328,413 |
(50,254) |
62,312 |
2,526,164 |
|
|
|
|
|
|
|
* Issue of ordinary
shares in the year (net of expenses) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Changes in Equity
For year ended 30 April 2022
|
|
|
|
|
|
Year
ended |
Year
ended |
|
|
30-Apr |
30-Apr |
|
|
2022 |
2021 |
|
|
(£) |
(£) |
Net cash from
operating activities |
|
|
|
Profit/ (Loss) before
tax |
|
2,561,803 |
245,886 |
Reverse provision for
share based payments |
|
19,603 |
13,756 |
Reverse (gains)/
losses on fair value investment through profit and loss |
|
(2,716,237) |
(411,992) |
Reverse losses/
(gains) on disposal of investments |
|
- |
1,476 |
Reverse net interest
expense |
|
876 |
1,063 |
|
|
|
|
Operating cash
outflows before movements in working capital |
|
(133,955) |
(149,811) |
|
|
|
|
|
|
|
|
Decrease in
receivables |
|
6,822 |
11,391 |
(Decrease) in
payables |
|
(3,845) |
(52,303) |
Tax paid |
|
- |
- |
|
|
|
|
|
|
2,977 |
(40,912) |
Cash outflow from
operating activities |
|
(130,978) |
(190,724) |
|
|
|
|
Investment
activities |
|
|
|
Interest received |
|
(1) |
14 |
Expenditure on equity
investments |
|
(42,462) |
(50,625) |
Proceeds
from sale of equity investments
through profit and loss |
|
- |
980 |
|
|
|
|
Cash (out)/ inflow
from investing activities |
|
(42,463) |
(49,631) |
|
|
|
|
Financing |
|
|
|
Issue of ordinary
share capital |
|
362,500 |
267,487 |
(Repayment)/Issue of
borrowings |
|
(7,500) |
50,000 |
Interest payable |
|
(876) |
(1,077) |
|
|
|
|
Cash in/ (out) flow
from financing activities |
|
354,124 |
316,410 |
|
|
|
|
Net increase in
cash and cash equivalents |
|
180,683 |
76,055 |
|
|
|
|
Cash and cash
equivalents at start of the financial year |
|
233,287 |
157,232 |
Cash and cash
equivalents at end of the financial year |
|
413,970 |
233,287 |
Notes to the Financial Statements
Year ended 30
April 2022
1. General information
Marechale Capital plc is a company registered in England and Wales under the Companies Act 2006. The
Company's principal activities are the provision of professional
services advice and broking services to companies. The financial
statements are presented in pounds sterling, the currency of the
primary economic environment in which the Company operates.
The Company's registered office and principal place of business
is 46 New Broad Street, London,
EC2M 1JH. The Company's registered number is 03515836.
2. Basis of preparation
a. Going concern
The company has unpredictable revenue due to the nature of
corporate finance advisory and the reliance upon deal-driven
transactions, however as at the year end the company had £414k of
cash reserves (2021: £233k) which at as that date equated to
approximately 10 months of overheads. Whilst the company generated
operating losses of £153k in the financial year (2021: £207k) the
directors remain confident that the project pipeline will generate
sufficient income on top of the cash reserves in order to meet the
company’s liabilities as they fall due over the next twelve months.
Furthermore, there is the ability to fund working capital by equity
issues, sales of equity investments and/or warrants and deferral of
directors’ salaries.
b. Basis of accounting
These financial statements have been prepared in accordance with
UK Adopted International Reporting Standards ('IFRS'). IFRS
Interpretations Committee ('IFRS IC') interpretations and the
Companies Act 2006 applicable to companies reporting under
IFRS.
The financial statements have been prepared on the historical
cost basis as modified by the valuation of certain financial
instruments, as described below.
The Directors have chosen not to prepare consolidated accounts
because the two subsidiaries, Marechale Ltd and Marechale Capital
Investments Ltd, are both dormant, have never traded, and therefore
highly immaterial to the financial statements.
Subsidiaries are entities over which the Group has control,
being the power to govern the financial and operating policies of
the acquired entity so as to obtain benefits from its
activities.
An associate is an entity over which the Group has significant
influence. Significant influence is the power to participate in the
financial and operating decisions of the investee, but it is not
control or joint control, over those policies.
3. Business and geographical
segments
The directors consider that there is only one activity
undertaken by the Company, that of corporate finance advisory. All
of this activity was undertaken in the United Kingdom.
|
|
2022 |
2021 |
|
|
£ |
£ |
|
|
|
|
Broking commissions
and fees earned from corporate finance |
|
621,573 |
399,929 |
4. Other gains/ (losses)
|
2022 |
2021 |
|
£ |
£ |
Realised (losses) on equity
investments |
- |
(1,476) |
Unrealised gains on equity
investments |
2,659,661 |
322,860 |
Unrealised gains on warrants |
56,576 |
89,132 |
|
2,716,237 |
410,516 |
5. Earnings per share
|
|
|
|
|
|
Earnings |
Earnings |
|
|
|
|
|
|
2022 |
2021 |
|
|
|
|
|
|
£ |
£ |
|
|
|
|
|
|
|
|
Based on a
gain/ (loss) of |
|
|
|
2,561,803 |
245,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No.
shares |
No.
shares |
Weighted
average number of Ordinary Shares in issue for the purpose of basic
earnings per share |
|
|
86,947,358 |
62,772,480 |
|
|
|
|
|
|
|
|
Weighted
average number of Ordinary Shares in issue for the purpose of
diluted earnings per share |
|
|
94,784,268 |
70,626,730 |
|
|
|
|
|
|
|
|
|
|
|
|
|
6. Other matters and Market Abuse
Regulation (MAR) Disclosure
The financial information for the year ended 30 April 2022 set out in this announcement does
not constitute statutory financial statements, as defined in
section 434 of the Companies Act 2006, but is based on the
statutory financial statements for the year then ended. The
auditors have issued an unqualified opinion on these financial
statements; their report included the following statement:
7. Valuation of investments including
options
The Directors have considered the fair value adjustment made on
the investments held at fair value through profit or loss. A net
upward fair value adjustment on the investments and options was
made to the total of £2,716,000 (2021: £410,000) consisting of
positive adjustments of £2,806,000 uplift on Weardale Lithium
Limited, offset by net negative adjustments on other companies.
This along with other valuations are estimates based on the
Directors’ assessment of the performance of the underlying
investment and reliable information such as recent fundraising.
There is however inherent uncertainty when valuing private
companies such as these in the natural resources sector.
8. Post balance sheet events
There are no post balance sheet events.